Segment Reporting - Schedule of Significant Expenses Provided to the CODM on a Regular Basis (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Segment Reporting [Line Items] | ||||||
| Stock-based compensation | $ 26,318 | $ 18,237 | ||||
| Net loss | $ 36,200 | $ 69,005 | $ 36,717 | $ 44,773 | 105,205 | 81,490 |
| Gain on sale of in-process research and development asset | 40,000 | 10,000 | 70,000 | 10,000 | ||
| Increase (decrease) in fair value of contingent value right liability | 4,600 | (600) | 34,900 | (1,800) | ||
| Related Party | ||||||
| Segment Reporting [Line Items] | ||||||
| Research and development, excluding compensation and share-based compensation | 0 | 0 | 3,100 | 2,600 | ||
| Operating Segments | Reportable Segment | ||||||
| Segment Reporting [Line Items] | ||||||
| Compensation | 12,862 | 8,120 | 24,305 | 15,111 | ||
| Stock-based compensation | 13,512 | 9,378 | 26,318 | 18,237 | ||
| Research and development, excluding compensation and share-based compensation | 50,447 | 30,749 | 97,340 | 64,300 | ||
| Other segment items | (40,621) | (11,530) | (42,758) | (16,158) | ||
| Net loss | $ 36,200 | $ 36,717 | $ 105,205 | $ 81,490 | ||
| X | ||||||||||
- Definition Increase (Decrease) In Fair Value Of Contingent Value Right Liability No definition available.
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Other employee benefit expense includes, but is not limited to, service component of net periodic benefit cost for defined benefit plan. Excludes compensation cost in cost of good and service sold. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|